Skip to main
BIOX

BIOX Stock Forecast & Price Target

BIOX Analyst Ratings

Based on 3 analyst ratings
Buy
Strong Buy 33%
Buy 33%
Hold 33%
Sell 0%
Strong Sell 0%

Bulls say

Bioceres Crop Solutions Corp demonstrates a strong underlying Crop Protection portfolio that has successfully retained market share outside Argentina, positioning the company favorably for a potential recovery in Argentine farmer demand. Robust international opportunities for its HB4 wheat revenue, particularly in the U.S., Brazil, and Australia, highlight the company's growth potential despite the initial time required for revenue ramp-up following partnerships. Additionally, the company's performance is bolstered by momentum in bio-protection products and adjuvant sales, which have offset weaker results in Argentina, further supporting a positive financial outlook.

Bears say

Bioceres Crop Solutions Corp has experienced a significant decline in top-line revenue, primarily attributed to weakened demand for its Crop Protection and Crop Nutrition solutions in Argentina, exacerbated by the transition to a licensing-based business model that excluded seed production, plant breeding, and seed sales. The Crop Nutrition segment reported a noteworthy decline of approximately 34% year-over-year, amounting to around $25 million, driven by reduced demand and pricing pressures, particularly in the micro-beaded fertilizer market influenced by a decrease in corn acreage. Furthermore, the Seed & Integrated products revenue plummeted nearly 75% year-over-year to approximately $8 million, highlighting the challenges faced during the shift to a seed technology business in collaboration with partners.

BIOX has been analyzed by 3 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 33% recommend Buy, 33% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Bioceres Crop Solutions Corp and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Bioceres Crop Solutions Corp (BIOX) Forecast

Analysts have given BIOX a Buy based on their latest research and market trends.

According to 3 analysts, BIOX has a Buy consensus rating as of Jan 11, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $4.33, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $4.33, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Bioceres Crop Solutions Corp (BIOX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.